Related Experiment Video
Updated: Jan 7, 2026
Using Nicotine in a Silica-Exposed Mouse Model to Promote Lung Epithelial-Mesenchymal Transition
Published on: March 3, 2023
Therapeutic Potential of Methanolic Extract of Areca catechu Nut in Treating Nicotine Use Disorder: evidence from
Dnyaneshwari Dhananjay Vibhute1, Pallavi Dorik1, Anushri Jadhav1
1Department of Pharmaceutical Sciences, School of Health Sciences and Technology, Dr. Vishwanath Karad MIT World Peace University (MIT-WPU), Kothrud, Pune, India.
Objectives:
Arecoline, the main bioactive compound in Areca catechu nut, interacts with nicotinic acetylcholine receptors (α4β2 and α7), suggesting potential in reducing nicotine cravings and withdrawal symptoms. This study evaluates the therapeutic potential of methanolic Areca catechu nut extract (MAN) against nicotine dependence and withdrawal in C57BL/6J mice.
Methods:
A modified runway model assessed nicotine-seeking behavior. Antidopaminergic effects and locomotor activity were measured via the haloperidol-induced catalepsy model and actophotometer. Behavioral models were used to evaluate MAN's effects on nicotine withdrawal symptoms anxiety (elevated plus maze, open field, marble burying), depression (forced swim, tail suspension), social interaction, anhedonia (sucrose preference), memory (elevated plus maze), and hyperalgesia (hot plate assay).
Results:
MAN (25 and 50 mg/kg, p.o.) showed antidopaminergic activity, reduced nicotine craving, and alleviated withdrawal symptoms (anxiety, depression, anhedonia, memory impairment, hyperalgesia) by enhancing serotonergic neurotransmission.
Conclusion:
MAN shows potential as a therapeutic candidate for nicotine use disorder.
Related Concept Videos
01:23Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
01:27CNS Depressants: Alcohol and Nicotine